What have we learned from ICON1 and ACTION?
Authors:
- 1 November 2003
- journal article
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 13 (s2) , 140-143
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Impact of Adjuvant Chemotherapy and Surgical Staging in Early-Stage Ovarian Carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm TrialJNCI: Journal of the National Cancer Institute, 2003
- International Collaborative Ovarian Neoplasm Trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm Trial: Two Parallel Randomized Phase III Trials of Adjuvant Chemotherapy in Patients With Early-Stage Ovarian CarcinomaJNCI: Journal of the National Cancer Institute, 2003
- Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinomaThe Lancet, 2001
- Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrumentAnnals of Oncology, 2000
- Second primary malignancies following the treatment of early stage ovarian cancer: Update of a study by the National Cancer Institute of Canada—Clinical Trials Group (NCIC—CTG)Annals of Oncology, 2000
- Estimates of the worldwide incidence of 25 major cancers in 1990International Journal of Cancer, 1999
- Adjuvant treatment for early epithelial ovarian cancer: Results of two randomised clinical trials comparing cisplatin to no further treatment or chromic phosphate (32P)Annals of Oncology, 1995
- Adjuvant Therapy in Stage I and Stage II Epithelial Ovarian CancerNew England Journal of Medicine, 1990
- The role of adjuvant therapy in Stage I ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1980